Clinical Data Disclosure, Transparency & Plain Language Summaries 2024 Conference Clinical Data Disclosure, Transparency & Plain Language Summaries 2024 CertaraFebruary 7, 2024
Drug Development’s New Model: Biosimulation from Discovery to Label Expansion On-Demand Webinar Drug Development’s New Model: Biosimulation from Discovery to Label Expansion Key Highlights: How predictive technologies reshape drug development, mitigating project risks, navigating novel biomarkers, predicting…CertaraFebruary 2, 2024
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference Press Release Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader…CertaraFebruary 1, 2024
Navigating Market Access for Healthcare Products: The Power of the Global Value Dossier Blog Navigating Market Access for Healthcare Products: The Power of the Global Value Dossier This blog defines the global value dossiers and explains how BaseCase can support creating interactive…CertaraJanuary 24, 2024
Navigating the “Patent Cliff”: Omni-channel Strategies for Loss of Exclusivity and Established Products On-Demand Webinar Navigating the “Patent Cliff”: Omni-channel Strategies for Loss of Exclusivity and Established Products Join us to understand the dynamics of the pharmaceutical market and learn how to maintain…CertaraJanuary 24, 2024
Understanding the Role of Your Discovery Asset’s Target Product Profile Blog Understanding the Role of Your Discovery Asset’s Target Product Profile If you work at a biotechnology start-up, you’re probably excited about your compound assets, particularly…CertaraJanuary 19, 2024
Streamlining Your NCA Workflow On-Demand Webinar Streamlining Your NCA Workflow PK analysis intended for submission contends with many data and compliance challenges. To work efficiently,…CertaraJanuary 18, 2024
Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database Publication Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database To assess real-world treatment patterns in patients diagnosed with hormone receptor positive (HR+), human epidermal…CertaraJanuary 17, 2024
Higher Standards: Achieving Cleaner Data, Faster, from Protocol to Submission On-Demand Webinar Higher Standards: Achieving Cleaner Data, Faster, from Protocol to Submission Join our webinar to explore best practices for harnessing the power of standards, without a…CertaraJanuary 16, 2024